Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (91-100 of 183) with videos related to

Pageof 19
Sort By:
European Journal of Pharmacology|December 14, 2004
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyEster Fride, Cfir Feigin, Datta E Ponde, et al.
Journal of Medicinal Chemistry|July 9, 2004
Synthesis and antitumor activity of quinonoid derivatives of cannabinoidsNatalya M Kogan, Ruth Rabinowitz, Paloma Levi, et al.
Neurobiology of Disease|December 21, 2005
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokinesDavid Panikashvili, Na'ama A Shein, Raphael Mechoulam, et al.
Molecular Cancer Therapeutics|January 24, 2007
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitorNatalya M Kogan, Michael Schlesinger, Esther Priel, et al.
Molecular Pharmacology|March 31, 2006
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cellsNatalya M Kogan, Cristina Blázquez, Luis Alvarez, et al.
European Journal of Pharmacology|February 6, 2003
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptorEster Fride, Anat Foox, Elana Rosenberg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 23, 2013
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injuryAyelet Cohen-Yeshurun, Dafna Willner, Victoria Trembovler, et al.
Inflammopharmacology|May 20, 2005
PADMA-28, a traditional Tibetan herbal preparation, blocks cellular responses to bFGF and IGF-IRoya Navab, Helena Aingorn, Lucia Fallavollita, et al.
Brain Research Bulletin|March 15, 2005
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in miceYosefa Avraham, Avshalom Ben Menachem, Avital Okun, et al.
Brain Research|January 2, 2007
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent propertiesMoisés García-Arencibia, Sara González, Eva de Lago, et al.
Pageof 19

Showing results (91-100 of 183) with videos related to

Sort By:
Pageof 19
European Journal of Pharmacology|December 14, 2004
(+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity onlyEster Fride, Cfir Feigin, Datta E Ponde, et al.
Journal of Medicinal Chemistry|July 9, 2004
Synthesis and antitumor activity of quinonoid derivatives of cannabinoidsNatalya M Kogan, Ruth Rabinowitz, Paloma Levi, et al.
Neurobiology of Disease|December 21, 2005
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokinesDavid Panikashvili, Na'ama A Shein, Raphael Mechoulam, et al.
Molecular Cancer Therapeutics|January 24, 2007
HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitorNatalya M Kogan, Michael Schlesinger, Esther Priel, et al.
Molecular Pharmacology|March 31, 2006
A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cellsNatalya M Kogan, Cristina Blázquez, Luis Alvarez, et al.
European Journal of Pharmacology|February 6, 2003
Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptorEster Fride, Anat Foox, Elana Rosenberg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 23, 2013
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injuryAyelet Cohen-Yeshurun, Dafna Willner, Victoria Trembovler, et al.
Inflammopharmacology|May 20, 2005
PADMA-28, a traditional Tibetan herbal preparation, blocks cellular responses to bFGF and IGF-IRoya Navab, Helena Aingorn, Lucia Fallavollita, et al.
Brain Research Bulletin|March 15, 2005
Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in miceYosefa Avraham, Avshalom Ben Menachem, Avital Okun, et al.
Brain Research|January 2, 2007
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent propertiesMoisés García-Arencibia, Sara González, Eva de Lago, et al.
Pageof 19